Godrej Agrovet Management Guidance Tracker
8 forward-looking guidance items tracked across 2 quarters.
Growth
Q3 FY26Astec Life Sciences: FY27 revenue growth target of 15%Tracked
Management targets 15% revenue growth for Astec in FY27, led by CDMO segment growing faster than enterprise.
Q3 FY26Oil palm: FFB tonnage growth of 12-15% on steady stateTrackedManagement expects steady-state FFB tonnage growth of 12-15% CAGR, supported by acreage expansion and productivity improvements.
Q4 FY26Mid-teens PBT growth in FY27ActiveTargeting mid-strong double-digit (mid-teens) PBT growth for FY27, building on FY26's 17.2% growth.
Margins
Q3 FY26Crop protection: Maintain 28-30% EBITDA margin in mid-termTracked
Management expects to sustain EBITDA margins in the 28-30% range for the crop protection business over the medium term.
Q3 FY26Astec: EBITDA breakeven for FY26ActiveManagement reiterated guidance for Astec to achieve EBITDA breakeven for the full year FY26.